Phase I clinical trial of 602 for healthy volunteers and patients with colorectal cancer
Latest Information Update: 19 Jun 2021
At a glance
- Drugs 602-3SBio (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
Most Recent Events
- 19 Jun 2021 New trial record